Author: Liumbruno, Giancarlo Maria; Franchini, Massimo
Title: Solvent/detergent plasma: pharmaceutical characteristics and clinical experience Cord-id: 5lnt5sp4 Document date: 2014_5_21
ID: 5lnt5sp4
Snippet: The solvent/detergent treatment is an established virus inactivation technology that has been industrially applied for manufacturing plasma derived medicinal products for almost 30 years. Solvent/detergent plasma is a pharmaceutical product with standardised content of clotting factors, devoid of antibodies implicated in transfusion-related acute lung injury pathogenesis, and with a very high level of decontamination from transfusion-transmissible infectious agents. Many clinical studies have co
Document: The solvent/detergent treatment is an established virus inactivation technology that has been industrially applied for manufacturing plasma derived medicinal products for almost 30 years. Solvent/detergent plasma is a pharmaceutical product with standardised content of clotting factors, devoid of antibodies implicated in transfusion-related acute lung injury pathogenesis, and with a very high level of decontamination from transfusion-transmissible infectious agents. Many clinical studies have confirmed its safety and efficacy in the setting of congenital as well as acquired bleeding disorders. This narrative review will focus on the pharmaceutical characteristics of solvent/detergent plasma and the clinical experience with this blood product.
Search related documents:
Co phrase search for related documents- action mechanism and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- action mechanism and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active bleeding and acute lung injury: 1
- active bleeding and acute respiratory syndrome: 1, 2
- acute lung injury and additional risk: 1
- acute respiratory syndrome and additional benefit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute respiratory syndrome and additional benefit provide: 1
- acute respiratory syndrome and additional cost: 1, 2, 3, 4, 5, 6
- acute respiratory syndrome and additional risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and additional risk factor: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date